Measured Wealth Private Client Group, LLC
Position in JNJ — Johnson & Johnson
CIK 1720235
PORTSMOUTH, NH
Position in JNJ
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$815,451
+$120,513 QoQ
Shares Held
3,336
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Measured Wealth Private Client Group, LLC holds $3,974,731 across 13 Drug Manufacturers - General names. JNJ ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
25,075 | $1,520,798 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
3,336 | $815,451 | |
| 3 | ABBV |
AbbVie Inc.
|
2,142 | $465,863 | |
| 4 | AMGN |
Amgen Inc
|
905 | $318,424 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,518 | $302,890 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,072 | $288,774 | |
| 7 | LLY |
ELI LILLY & Co
|
114 | $104,853 | |
| 8 | PFE |
Pfizer Inc
|
2,283 | $64,106 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $815,451 | 3,336 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $694,938 | 3,358 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $625,050 | 3,371 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $537,832 | 3,521 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $557,885 | 3,364 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $499,951 | 3,457 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $563,320 | 3,476 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $710,483 | 4,861 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $798,543 | 5,048 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $791,223 | 5,048 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $840,427 | 5,396 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $885,200 | 5,348 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $816,850 | 5,270 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $957,796 | 5,422 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $869,401 | 5,322 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $976,837 | 5,503 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $1,003,653 | 5,663 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,062,344 | 6,210 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,017,288 | 6,299 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,283,324 | 7,790 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,173,130 | 7,138 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,398,793 | 8,888 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $1,419,273 | 9,533 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $1,188,464 | 8,451 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $776,420 | 5,921 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||